References
- Benedetto AD, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol. 2012;132:949-963. https://doi.org/10.1038/jid.2011.435
- Hudson TJ. Skin barrier function and allergic risk. Nat Genet. 2006;38(4):399-400. https://doi.org/10.1038/ng0406-399
- Melik-Parsadaniantz S, Rostene W. Chemokines and neuromodulation. J Neuroimmunol. 2008;198(1-2):62-68. https://doi.org/10.1016/j.jneuroim.2008.04.022
- Qi XF, Kim DH, Yoon YS, Li JH, Jin D, Teng YC, Kim SK, Lee KJ. Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line. Br J Pharmacol. 2009;157:1441-1450. https://doi.org/10.1111/j.1476-5381.2009.00311.x
- Pivarcsi A, Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr Allergy Asthma Rep. 2005;5(4):284-290. https://doi.org/10.1007/s11882-005-0068-y
- Barker JN, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ. Marked synergism between tumor necrosis factor-alpha and interferongamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest. 1990;85(2):605-608. https://doi.org/10.1172/JCI114481
- Amarbayasgalan T, Takahashi H, Dekio I, Morita E. Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis. Int Arch Allergy Immunol. 2013;16(1)0:63-74. https://doi.org/10.1159/000339666
- Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci. 2006;43(2):75-84. https://doi.org/10.1016/j.jdermsci.2006.06.002
- Najjar I, Fagard R. STAT1 and pathogens, not a friendly relationship. Biochimie. 2010;92(5):425-444. https://doi.org/10.1016/j.biochi.2010.02.009
- Akira S. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells. 1999;17(3):138-146. https://doi.org/10.1002/stem.170138
- Ju SM, Song HY, Lee SJ, Seo WY, Sin DH, Goh AR, Kang YH, Kang IJ, Won MH, Yi JS, Kwon DJ, Bae YS, Choi SY, Park JS. Suppression of thymus-and activation-regulated chemokine (TARC/CCL17) production by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose via blockade of NF-kappaB and STAT1 activation in the HaCaT cells. Biochem Biophys Res Commun. 2009;387(1):115-120. https://doi.org/10.1016/j.bbrc.2009.06.137
- Kwon DJ, Bae YS, Ju SM, Goh AR, Youn GS, Choi SY, Park J. Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-kappaB and STAT1 activation in HaCaT cells. Biochem Biophys Res Commun. 2012;417(4):1254-1259. https://doi.org/10.1016/j.bbrc.2011.12.119
- Sung YY, Kim HK. Illicium verum extract suppresses IFN-gammainduced ICAM-1 expression via blockade of JAK/STAT pathway in HaCaT human keratinocytes. J Ethnopharmacol. 2013:149(3);626-632. https://doi.org/10.1016/j.jep.2013.07.013
- Kang GJ, Dang HT, Han SC, Kang NJ, Koo DH, Koh YS, Hyun JW, Kang HK, Jung JH, Yoo ES. Methyl 5-chloro-4,5-didehydrojasmonate (J7) inhibits macrophage-derived chemokine production via down-regulation of the signal transducers and activators of transcription 1 pathway in HaCaT human keratinocytes. Chem Pharm Bull. 2013;61(10):1002-1008. https://doi.org/10.1248/cpb.c13-00145
- Han EH, Hwang YP, Choi JH, Yang JH, Seo JK, Chung YC, Jeong HG. Psidium guajava extract inhibits thymus and activationregulated chemokine (TARC/CCL17) production in human keratinocytes by inducing heme oxygenase-1 and blocking NF-kappaB and STAT1 activation. Environ Toxicol Pharmacol. 2011;32(2):136-145. https://doi.org/10.1016/j.etap.2011.04.004
- Hongqin T, Xinyu L, Heng G, Lanfang X, Yongfang W, Shasha S. Triptolide inhibits IFN-gamma signaling via the Jak/STAT pathway in HaCaT keratinocytes. Phytotherapy Research. 2011;25(11):1678-1685. https://doi.org/10.1002/ptr.3471
- Kim IR KH, Kuk YB, Park SJ, Park YK, Park JH, Seo BI, Seo YB, Shin MK, Lee YJ, LeeYC, Lee JH, Leem KH, Cho SI, Chung JK, Joo YS, Choi HY. Boncho-Hak. Seoul : Young-Lim Press. 2007 : 671-2.
- Park JO. Effects of methanol extract from Terminalia chebulae on renal and pulmonary toxicities induced by paraquat in rats. J Life Sci 2008;8:129-135. https://doi.org/10.5352/JLS.2008.18.1.129
- Lee KS, Kim SH, Sim KC, Park CS, Shin YS. Antimicrobial activity of Terminalia chebula Retz. extract of against intestinal pathogens. Korean J Food & Nutr 1997;10: 559-563.
- Achari C, Reddy GV, Reddy TC, Reddanna P. Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1. Med Chem. 2011;7:432-442. https://doi.org/10.2174/157340611796799087
- Bag A, Kumar Bhattacharyya S, Kumar Pal N, Ranjan Chattopadhyay R. Anti-inflammatory, anti-lipid peroxidative, antioxidant and membrane stabilizing activities of hydroalcoholic extract of Terminalia chebula fruits. Pharm Biol. 2013;51(12):1515-1520. https://doi.org/10.3109/13880209.2013.799709
- Silawat N, Gupta VB. Chebulic acid attenuates ischemia reperfusion induced biochemical alteration in diabetic rats. Pharm Biol. 2013;51:23-29. https://doi.org/10.3109/13880209.2012.698288
- Kesharwani A, Polachira SK, Nair R, Agarwal A, Mishra NN, Gupta SK. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement Altern Med. 2017;17(1):110. https://doi.org/10.1186/s12906-017-1620-8
- Patil VS, Harish DR, Vetrivel U, Roy S, Deshpande SH, Hegde HV. Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula: A Structural Perspective. Molecules. 2022;27(3):1076. https://doi.org/10.3390/molecules27031076
- Saleem A, Husheem M, Harkonen P, Pihlaja K. Inhbition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol. 2002;81:327-336. https://doi.org/10.1016/S0378-8741(02)00099-5
- Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81:155-160. https://doi.org/10.1016/S0378-8741(02)00034-X
- Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int J Antimicrob Ag. 2001;18:85-88. https://doi.org/10.1016/S0924-8579(01)00352-1
- Jagtap AG, Karkera SG. Potential aqueous extract of Terminalia Chebula as an anticaries agent. J Ethnopharmocol. 1999;68:299-306. https://doi.org/10.1016/S0378-8741(99)00058-6
- Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014;14:289-301. https://doi.org/10.1038/nri3646
- Abramovits W. Atopic dermatitis. J Am Acad Dermatol. 2005;53:86-93.
- Pastore S, Mascia F, Girolomoni G. The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol. 2006;16:125-131.
- Jo IJ, Choi MO. Protective Effects of Kyungohkgo on Atopic Dermatitis in HaCaT Cells. J Kor Soc Cosmetol. 2020;27(5):1286-1292.
- Wuthrich B. Epidemiology of the allergic diseases: are they really on the increase? Int Arch Allergy Appl Immunol. 1989;90:3-10. https://doi.org/10.1159/000235067
- Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol. 2002;14(1):129-135. https://doi.org/10.1016/S0952-7915(01)00308-9
- Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy. 2005;60(5):685-688. https://doi.org/10.1111/j.1398-9995.2005.00774.x
- Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999;400(6746):776-780. https://doi.org/10.1038/23495
- Song TW, Sohn MH, Kim ES, Kim KW, Kim KE. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis. Clin Exp Allergy. 2006;36(3):346-351. https://doi.org/10.1111/j.1365-2222.2006.02430.x
- Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, Shinomiya N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol. 2008;19(7):605-613. https://doi.org/10.1111/j.1399-3038.2007.00692.x
- Qi XF, Kim DH, Yoon YS, Li JH, Song SB, Jin D, Huang XZ, Teng YC, Lee KJ. The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes. Mol Immunol. 2009;46(10):1925-1934. https://doi.org/10.1016/j.molimm.2009.03.018
- Kim WH, An HJ, Kim JY, Gwon MG, Gu H, Lee SJ, Park JY, Park KD, Han SM, Kim MK, Park KK. Apamin inhibits TNF-α-and IFN-γ-induced inflammatory cytokines and chemokines via suppressions of NF-κB signaling pathway and STAT in human keratinocytes. Pharmacol Rep. 2017;69(5):1030-1035. https://doi.org/10.1016/j.pharep.2017.04.006
- Kovacic JC, Gupta R, Lee AC, Ma M, Fang F, Tolbert CN, Walts AD, Beltran LE, San H, Chen G, St Hilaire C, Boehm M. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest. 2010;120(1):303-314. https://doi.org/10.1172/JCI40364